1. Home
  2. BIAF
  3. BIAF News

Latest bioAffinity Technologies Inc. (BIAF) News on November 18, 2025

bioAffinity Technologies Reports Third Quarter 2025 Financial Results
BIAF

Business Wire

4 days ago

bioAffinity Technologies Reports Third Quarter 2025 Financial Results

bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume
BIAF

Business Wire

13 days ago

bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume

BIAF

Business Wire

21 days ago

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
BIAF

Business Wire

a month ago

bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer
BIAF

Business Wire

a month ago

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
BIAF

Business Wire

a month ago

bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements

BIAF

MT Newswires

a month ago

Sector Update: Health Care Stocks Softer Late Afternoon

BIAF

MT Newswires

a month ago

Sector Update: Health Care

WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
BIAF

PR Newswire

a month ago

WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

BIAF

MT Newswires

a month ago

BioAffinity Technologies Closes $1.8 Million Registered Direct Offering

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
BIAF

Business Wire

a month ago

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

BIAF

MT Newswires

a month ago

bioAffinity Technologies Launches $1.8 Million Registered Direct Offering

WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
BIAF

PR Newswire

a month ago

WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
BIAF

Business Wire

a month ago

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference
BIAF

Business Wire

5 months ago

bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference

bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy
BIAF

Business Wire

5 months ago

bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy

bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board
BIAF

Business Wire

5 months ago

bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board

bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung
BIAF

Business Wire

5 months ago

bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung

BioAffinity Technologies Secures Patent for Novel Cancer Therapy Targeting CD320 and LRP2 Receptors
BIAF

Insider Monkey

6 months ago

BioAffinity Technologies Secures Patent for Novel Cancer Therapy Targeting CD320 and LRP2 Receptors

bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics
BIAF

Business Wire

6 months ago

bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics

BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline
BIAF

Zacks

6 months ago

BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline

bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
BIAF

Business Wire

6 months ago

bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer

bioAffinity Technologies Reports First Quarter 2025 Results
BIAF

Business Wire

6 months ago

bioAffinity Technologies Reports First Quarter 2025 Results

Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer
BIAF

Business Wire

6 months ago

Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer

BIAF

MT Newswires

6 months ago

BioAffinity Technologies Closes $3.25 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.25m Offering
BIAF

PR Newswire

6 months ago

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.25m Offering

bioAffinity Technologies Announces Closing of $3.25 Million Offering
BIAF

Business Wire

6 months ago

bioAffinity Technologies Announces Closing of $3.25 Million Offering

BioAffinity Technologies announces pricing of $3.25M offering
BIAF

TipRanks

6 months ago

BioAffinity Technologies announces pricing of $3.25M offering

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.25m Offering
BIAF

PR Newswire

6 months ago

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.25m Offering

bioAffinity Technologies Announces Pricing of $3.25 Million Offering
BIAF

Business Wire

6 months ago

bioAffinity Technologies Announces Pricing of $3.25 Million Offering

The Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity Technologies
BIAF

Zacks

6 months ago

The Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity Technologies

Top Stock Reports for Alphabet, Berkshire Hathaway & Visa
BIAF

Zacks

6 months ago

Top Stock Reports for Alphabet, Berkshire Hathaway & Visa

bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
BIAF

Business Wire

7 months ago

bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost

BIAF

ACCESS Newswire

7 months ago

ASP Isotopes and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues
BIAF

Zacks

7 months ago

BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues

bioAffinity Technologies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
BIAF

Simply Wall St.

8 months ago

bioAffinity Technologies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024
BIAF

Business Wire

8 months ago

bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024

BIAF

ACCESS Newswire

8 months ago

bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
BIAF

Business Wire

8 months ago

Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer

Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence
BIAF

Business Wire

8 months ago

Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence

Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer
BIAF

Business Wire

8 months ago

Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth
BIAF

Business Wire

8 months ago

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth

BIAF

MT Newswires

9 months ago

bioAffinity Technologies Raises $1.4 Million After Warrant Exercise

WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million
BIAF

PR Newswire

9 months ago

WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million
BIAF

Business Wire

9 months ago

bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

WallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million
BIAF

PR Newswire

9 months ago

WallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million
BIAF

Business Wire

9 months ago

bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

Zacks Initiates Coverage of bioAffinity With Neutral Recommendation
BIAF

Zacks

9 months ago

Zacks Initiates Coverage of bioAffinity With Neutral Recommendation

The Zacks Analyst Blog Highlights Amazon, Bank of America, Caterpillar, NVE and bioAffinity
BIAF

Zacks

9 months ago

The Zacks Analyst Blog Highlights Amazon, Bank of America, Caterpillar, NVE and bioAffinity

Top Research Reports for Amazon.com, Bank of America & Caterpillar
BIAF

Zacks

9 months ago

Top Research Reports for Amazon.com, Bank of America & Caterpillar

BIAF

MT Newswires

10 months ago

BioAffinity Technologies Says Australian Patent Office Accepts Lung Cancer Test Application

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
BIAF

Business Wire

10 months ago

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic

bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung
BIAF

Business Wire

10 months ago

bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung

Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
BIAF

ACCESSWIRE

10 months ago

Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

bioAffinity Technologies Boosts Sales with CyPath Lung
BIAF

TipRanks

a year ago

bioAffinity Technologies Boosts Sales with CyPath Lung

Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19
BIAF

Business Wire

a year ago

Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19

bioAffinity Technologies Set for Continued Expansion in 2025
BIAF

Business Wire

a year ago

bioAffinity Technologies Set for Continued Expansion in 2025

Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule
BIAF

Business Wire

a year ago

Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
BIAF

Business Wire

a year ago

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
BIAF

Business Wire

a year ago

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development

BIAF

MT Newswires

a year ago

bioAffinity Technologies Secures Japanese Patent for Lung Cancer Diagnostic Method

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
BIAF

Business Wire

a year ago

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung

WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement
BIAF

PR Newswire

a year ago

WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement
BIAF

Business Wire

a year ago

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement

WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement
BIAF

PR Newswire

a year ago

WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement

bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
BIAF

Business Wire

a year ago

bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement

bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
BIAF

Business Wire

a year ago

bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines

BIAF

MT Newswires

a year ago

BioAffinity Technologies Appoints J. Michael Edwards as CFO

bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer
BIAF

Business Wire

a year ago

bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer

bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test
BIAF

Business Wire

a year ago

bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis
BIAF

Business Wire

a year ago

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis

bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO
BIAF

Business Wire

a year ago

bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO

bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales
BIAF

Business Wire

a year ago

bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales

BIAF

MT Newswires

a year ago

BioAffinity Raises Nearly $1.8 Million From Offerings

bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
BIAF

Business Wire

a year ago

bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
BIAF

PR Newswire

a year ago

WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
BIAF

Business Wire

a year ago

bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
BIAF

ACCESSWIRE

a year ago

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung
BIAF

Business Wire

a year ago

bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung

BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
BIAF

ACCESSWIRE

a year ago

BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
BIAF

Business Wire

a year ago

bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
BIAF

Business Wire

2 years ago

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes

bioAffinity Technologies News Update
BIAF

Business Wire

2 years ago

bioAffinity Technologies News Update

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
BIAF

Business Wire

2 years ago

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
BIAF

Business Wire

2 years ago

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
BIAF

Business Wire

2 years ago

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
BIAF

PR Newswire

2 years ago

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
BIAF

Business Wire

2 years ago

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
BIAF

PR Newswire

2 years ago

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
BIAF

Business Wire

2 years ago

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
BIAF

Business Wire

2 years ago

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

Here's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation
BIAF

Simply Wall St.

2 years ago

Here's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation

bioAffinity Technologies News Update
BIAF

Business Wire

2 years ago

bioAffinity Technologies News Update

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice
BIAF

Business Wire

2 years ago

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

bioAffinity Technologies In The News
BIAF

Business Wire

2 years ago

bioAffinity Technologies In The News

BM Technologies (BMTX) Champions Campus Excellence and Announces 2023 ACE Award and Partnership Winners
BIAF

ACCESSWIRE

2 years ago

BM Technologies (BMTX) Champions Campus Excellence and Announces 2023 ACE Award and Partnership Winners

Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow
BIAF

GlobeNewswire

2 years ago

Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
BIAF

Business Wire

2 years ago

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Orion (OESX) Preliminary Q3 Results Depict Strong Demand
BIAF

Zacks

2 years ago

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

MAIA Soars 20% on Interim Results From Lung Cancer Study
BIAF

Zacks

2 years ago

MAIA Soars 20% on Interim Results From Lung Cancer Study

Share on Social Networks: